Full-Time

Locums Physician Recruiter

Updated on 9/10/2026

AMN Healthcare

AMN Healthcare

1,001-5,000 employees

Total talent solutions for healthcare staffing

Compensation Overview

$19.50 - $24.25/hr

+ Bonus + Commission

Dallas, TX, USA

In Person

Office attendance is required at a frequency determined by the work arrangement.

Bachelor's

Category
People & HR (1)
Required Skills
Applicant Tracking Software (ATS)
Sales
CRM

Get referred to AMN Healthcare

See people who can refer or advise you

Requirements
  • The candidate must have 2+ years of agency recruiting or sales experience.
  • The candidate must have a Bachelor's Degree or equivalent combination of education and experience.
  • The candidate must demonstrate success in quota-based or performance-driven roles.
  • The candidate must have strong closing skills and the ability to influence physician decision-making.
  • The candidate must have experience managing high-volume requisitions and competing priorities.
  • The candidate must be comfortable with outbound calling and consultative selling.
  • The candidate must have working knowledge of locum tenens workflows, credentialing timelines, and compliance requirements.
  • The candidate must have strong communication, organization, and follow-through skills.
Responsibilities
  • Recruit, qualify, and close locum tenens physicians across multiple specialties to meet urgent and ongoing client coverage needs.
  • Own full-cycle locums recruiting with a sales execution mindset, from outbound sourcing through placement.
  • Consistently meet or exceed individual key performance indicators and productivity metrics, including calls, submittals, interviews, and placements.
  • Proactively source physicians using Boolean search techniques, applicant tracking system/customer relationship management tools, referrals, and outbound sales-style outreach.
  • Sell locum tenens opportunities to physicians by aligning assignment details with availability, pay expectations, and lifestyle preferences.
  • Build and maintain a strong physician pipeline to support repeat placements and long-term revenue generation.
  • Partner with account managers, credentialing, licensing, and travel teams to ensure fast, efficient placements.
  • Accurately track activity, pipeline health, and conversion metrics in applicant tracking system/customer relationship management systems.
  • Navigate physician objections related to schedule, location, compensation, and competing opportunities.
  • Operate with urgency and discipline in a metrics-based, quota-driven environment.
  • Manage a full desk with multiple active physicians and assignments.
  • Manage daily and weekly activity, including calls, outreach, and submissions; interview-to-placement conversion rates; assignment fill rate; and physician redeployments.
  • Use strong time management and prioritization in a fast-paced production environment.
Desired Qualifications
  • Prior locums tenens agency experience.
  • Healthcare staffing, physician staffing, or adjacent business-to-business sales background.
  • Familiarity with physician licensure, credentialing processes, and time-sensitive coverage needs.

AMN Healthcare provides total talent solutions for healthcare organizations across the United States, connecting facilities with a large network of healthcare professionals. It manages the entire talent lifecycle with services such as managed services programs (MSP), vendor management systems (VMS), recruitment process outsourcing (RPO), executive search, temporary staffing, credentialing, language interpretation, and revenue cycle solutions. The platform uses data-driven insights to recruit, place, credential, and manage clinicians, aiming to reduce complexity, improve staffing efficiency, and support better patient care. It differentiates itself by offering end-to-end workforce management in one ecosystem, backed by a nationwide network and specialized back-office services that go beyond traditional staffing.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1985

Get referred to AMN Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • AMN’s Q2 2026 revenue hit $673.2 million, beating guidance by 6% on August 6.
  • Travel nurse volume rose 6%, allied volume 7%, and search revenue 27% year over year.
  • Management raised Q3 2026 outlook to $640 million-$655 million and bought back shares.

What critics are saying

  • AMN settled a California privacy class action for $4.5 million on August 7, 2026.
  • Language-services pricing fell 8% year over year in Q2 2026, crushing margins.
  • Technology and Workforce Solutions revenue dropped 15% in Q2 2026; VMS fell 20%.

What makes AMN Healthcare unique

  • AMN’s June 2026 Jaide acquisition pairs human interpreters with AI-enabled intake and discharge workflows.
  • AMN’s 2,300-system client base and WorkWise platform create sticky workforce-management relationships.
  • AMN combines staffing, search, VMS, RPO, and credentialing across acute and nonacute care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

MarketBeat
Sep 2nd, 2026
Zacks Research brokers boost earnings estimates for AMN.

Zacks Research brokers boost earnings estimates for AMN. September 2, 2026 Key points. * Zacks Research raised AMN Healthcare Services' Q3 2026 EPS estimate to $0.21 from $0.20, while maintaining a "Hold" rating. Its full-year 2026 EPS forecast is $3.25, compared with the broader consensus of $3.31. * AMN recently exceeded quarterly expectations, reporting $0.77 EPS versus the $0.19 consensus and revenue of $673.24 million versus $628.39 million. Revenue increased 2.3% year over year. * Analyst sentiment remains mixed, with a consensus "Hold" rating and average price target of $31.43; the stock recently opened at $33.42. Institutional investors own approximately 99.23% of outstanding shares. * MarketBeat previews the top five stocks to own by October 1st. AMN Healthcare Services Inc (NYSE:AMN - Free Report) - Analysts at Zacks Research raised their Q3 2026 EPS estimates for AMN Healthcare Services in a note issued to investors on Tuesday, September 1st. Zacks Research analyst Team now anticipates that the company will post earnings of $0.21 per share for the quarter, up from their previous estimate of $0.20. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for AMN Healthcare Services' current full-year earnings is $3.31 per share. Zacks Research also issued estimates for AMN Healthcare Services' Q4 2026 earnings at $0.17 EPS, FY2026 earnings at $3.25 EPS, Q1 2027 earnings at $0.17 EPS, Q2 2027 earnings at $0.24 EPS, Q3 2027 earnings at $0.33 EPS, Q1 2028 earnings at $0.24 EPS and FY2028 earnings at $1.36 EPS. AMN Healthcare Services (NYSE:AMN - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.19 by $0.58. AMN Healthcare Services had a net margin of 3.06% and a return on equity of 19.92%. The business had revenue of $673.24 million during the quarter, compared to analysts' expectations of $628.39 million. During the same period in the previous year, the business posted $0.30 EPS. The business's quarterly revenue was up 2.3% compared to the same quarter last year. Several other brokerages have also commented on AMN. UBS Group upped their price target on AMN Healthcare Services from $32.00 to $35.00 and gave the company a "neutral" rating in a research note on Friday, August 7th. BMO Capital Markets lifted their price objective on AMN Healthcare Services from $25.00 to $26.00 and gave the company an "outperform" rating in a research note on Monday, May 11th. Wall Street Zen lowered AMN Healthcare Services from a "buy" rating to a "hold" rating in a research note on Tuesday, August 25th. Robert W. Baird set a $36.00 price target on shares of AMN Healthcare Services in a research report on Friday, August 7th. Finally, Citigroup restated an "outperform" rating on shares of AMN Healthcare Services in a report on Friday, August 14th. Four research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat, AMN Healthcare Services presently has a consensus rating of "Hold" and an average target price of $31.43. Discover more AMN Healthcare Services price performance. AMN Healthcare Services stock opened at $33.42 on Wednesday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.13 and a current ratio of 1.13. The company's fifty day moving average price is $33.73 and its 200 day moving average price is $26.81. AMN Healthcare Services has a 1 year low of $14.97 and a 1 year high of $37.22. The stock has a market capitalization of $1.29 billion, a P/E ratio of 12.47, a P/E/G ratio of 1.18 and a beta of 0.38. Institutional trading of AMN Healthcare Services. Institutional investors have recently bought and sold shares of the business. Summit Securities Group LLC purchased a new position in shares of AMN Healthcare Services in the 4th quarter valued at about $32,000. Versant Capital Management Inc raised its holdings in AMN Healthcare Services by 41.8% during the second quarter. Versant Capital Management Inc now owns 1,170 shares of the company's stock worth $38,000 after purchasing an additional 345 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in AMN Healthcare Services during the third quarter worth approximately $63,000. Tower Research Capital LLC TRC lifted its position in shares of AMN Healthcare Services by 49.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,093 shares of the company's stock worth $64,000 after buying an additional 1,020 shares during the last quarter. Finally, Allworth Financial LP purchased a new stake in shares of AMN Healthcare Services during the 2nd quarter worth approximately $65,000. 99.23% of the stock is owned by hedge funds and other institutional investors. Insider activity at AMN Healthcare Services. In other news, Director Mark G. Foletta sold 3,681 shares of the firm's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $31.07, for a total value of $114,368.67. Following the sale, the director directly owned 17,917 shares in the company, valued at approximately $556,681.19. This trade represents a 17.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.07% of the company's stock. AMN Healthcare Services company profile. AMN Healthcare Services, Inc NYSE: AMN is a leading provider of healthcare workforce solutions in the United States. The company specializes in staffing and recruitment services for a broad range of clinical and allied health professionals, including travel nurses, permanent placement of nursing staff, locum tenens physicians, and allied health personnel. In addition to direct staffing, AMN Healthcare offers comprehensive workforce management solutions such as vendor management systems (VMS), recruitment process outsourcing (RPO), and compliance and credentialing services through its technology platforms. Founded in 1985 as American Mobile Nurses, the company rebranded to AMN Healthcare in 2010 to reflect its expanding portfolio of services. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Continue following MarketBeat Before you consider AMN Healthcare Services, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMN Healthcare Services wasn't on the list. While AMN Healthcare Services currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

LocReport
Aug 18th, 2026
AMN Healthcare integrates AI interpreting amid pricing pressures.

AMN Healthcare integrates AI interpreting amid pricing pressures. AMN Healthcare is strategically steering towards AI-enabled interpretation as financial pressures tighten around their traditional revenue streams. This move involves the recent acquisition of Jaide Health, a company whose technology facilitates routine healthcare communication, addressing vital interactions such as patient intake. Amidst a pricing downturn, AMN aims to leverage this technology to counterbalance declining rates in language services, a sector that's seen an 8% revenue drop in Q2 2026, compared to the previous year, as reported by Slator. The integration of AI solutions comes at a critical time when AMN's overall revenue from language services has shown only a marginal 1% recovery from Q1 2026 while witnessing a consistent compression in pricing. Specifically, interpreting service prices have diminished by 8% year-over-year and by 3% sequentially from Q1 2026. This trend signals a challenging market landscape where cost pressures and competition are prominent. It appears AMN is banking on AI-driven efficiencies to bolster performance and eventually enhance the gross margins of their language services by 2027. The financial narrative is coupled with AMN's broader economic landscape where the Technology and Workforce Solutions segment has also experienced a downturn. A 15% decline in revenue for this division in Q2 2026 reflects broader operational challenges, though AMN has demonstrated resilience by bouncing back from a significant USD 116.2 million loss in Q2 2025, realizing a USD 21.2 million net income in Q2 2026. The expected revenue for Q3 2026 remains between USD 640 million to 655 million, despite a forecasted 11% to 13% decline in the Technology and Workforce Solutions' revenue for the same period. These projections underscore the need for innovative strategies like the Jaide acquisition to sustain future growth. Ultimately, AMN Healthcare's pivot towards AI in medical interpreting represents a decisive response to a complex and evolving market. With competitive pricing eroding traditional revenue streams, adopting advanced technology not only aligns with industry trends but also positions the company for enhanced operational efficiency. As noted by Cary Grace, AMN's CEO and President, managing through client renewals and acquisitions will be crucial in navigating the headwinds described in Slator. Intelligence. Why this matters * AI integration aims to counteract revenue declines. * Acquisition of Jaide Health enhances healthcare communication. * Strategic pivot aligns with industry trends for efficiency. LSPs Enterprise Buyers Related reading. Keep independent coverage alive. No ads. No paywall. No corporate backing. Just sharp, weekly intelligence on the language industry - free, because it should be.

Yahoo Finance
Aug 14th, 2026
AMN Healthcare beats Q2 2026 guidance with $673M revenue, up 2% year-over-year

AMN Healthcare reported second quarter 2026 results that exceeded expectations, with consolidated revenue of $673 million, 6% above the high end of guidance and 2% higher year-over-year. Five of the company's solutions segments grew revenue compared to the prior year. Adjusted EBITDA reached $73 million, representing 10.9% of revenue and up 26% year-over-year. Adjusted earnings per share came in at $0.77, compared with $0.30 in the same quarter last year. The healthcare staffing company ended the quarter with $362 million in cash. Management indicated this provides capacity to invest in long-term strategy, including potential acquisitions. President and chief executive officer Caroline Grace said the quarterly performance came in better than the company had forecasted.

Yahoo Finance
Aug 7th, 2026
AMN Healthcare Q2 revenue rises 2% to $673M, boosted by travel nurse demand and labor disruption

AMN Healthcare Services reported second-quarter results exceeding guidance, with revenue rising 2% year-over-year to $673 million. Adjusted EBITDA increased 26% to $73 million, whilst adjusted EPS reached $0.77, up from $0.30 in the prior-year quarter. Results benefited from $27 million in labour-disruption revenue and favourable reserve adjustments. The nurse and allied staffing segment showed significant strength, with revenue growing 11%. Travel nurse volume rose 6% and allied volume increased 7%, with travel nurse orders up approximately 40% year-over-year by early August. Performance varied across other businesses: search revenue grew 27%, but locums revenue fell 8% and technology and workforce solutions declined 15%. The company forecast third-quarter revenue of $640 million to $655 million, with adjusted EBITDA margins of 6.5% to 7%. AMN ended the quarter with $362 million in cash and equivalents.

Yahoo Finance
Aug 6th, 2026
AMN Healthcare beats Q2 revenue estimates with $673M, stock surges 11.5%

AMN Healthcare Services reported second-quarter 2026 results that exceeded Wall Street expectations, with revenue of $673.2 million, up 2.3% year-on-year and beating analyst estimates of $628.2 million. The healthcare staffing company's non-GAAP earnings of $0.77 per share significantly surpassed the $0.19 consensus estimate. The company's third-quarter revenue guidance of $647.5 million at the midpoint came in 4.7% above analyst expectations. Adjusted EBITDA reached $73.36 million, beating estimates by 69.5%. Following the announcement, AMN Healthcare Services' stock jumped 11.5%. The company's operating margin improved to 4%, compared with negative 18.8% in the same quarter last year. Sales volumes increased 5.7% year-on-year. Free cash flow declined to negative $198.9 million from $68.75 million in the prior-year quarter.